1 Bille BS.Migraine in school children:a study of the incidence and short-term prognosis,and a clinical,psychological and electroencephalographic comparison between children with migraine and matched controls.Acta Paediatr Scand,51(Suppl 136):1-151. 2 Merison K,Diagnosis and treatment of childhood migraine.Curr Treat Options Neurol,2016,18:48. 3 Wöber-Bingöl C,Epidemiology of migraine and headache in children and adolescents.Curr Pain Headache Rep,2013,17:341. 4 Genizi J,Matar AK,Zelnik N,et al.Frequency of pediatric migraine with aura in a clinic-based sample.Headache,2016,56:113-117. 5 Pacheva IH,Ivanov IS,Migraine variants—occurrence in pediatric neurology practice.Clin Neurol Neurosurg,2013,115:1775-1783. 6 Steiner TJ,Stovner LJ,Birbeck GL.Migraine:the seventh disabler.J Headache Pain,2013,14 :1. 7 许新炜.偏头痛发病机制生化因素研究进展.中西医结合心血管病杂志,2018,6:12. 8 Peroutka S,What turns on a migraine? A systematic review of migraine precipitating factors.Curr Pain Headache Rep,2014,18:454. 9 赵维,张波,偏头痛发病机制的研究进展.中医药临床杂志,2015,27:125-127. 10 Suthe Rl,and Hg,Griffiths Lr,Genetics of migraine:insights into the molecular basis of migraine disorder.Headache,2017,57:537-569. 11 Nagy C,Bajzik G,Skobrak A,et al,Childhood sporadic type of hemiplegic migraine with arteria cerebrimedia hypoperfusion.Ideggyogy SZ,2017,70:343-348. 12 Sprenger T,Viana M,Tassorelli C,Current prophylactic medications for migraine and Their potentual mechanisms of action.Neurotherapeatics,2018,15:313-323. 13 Kroner JW,Hershey AD,Kashikar-Zuck SM,et al.Cognitive behavioral therapy plus amitriptyline for children and adolescents with chronic migraine reduces headache days to ≤4 per month.Headache,2016;56:711-716. 14 张旭,黄志.儿童偏头痛的治疗进展.现代医药卫生,2016,32:2847-2851. 15 Toldo I,De Carlo D,Bolzonella B,et al.The pharmacological treatment of migraine in children and adolescents:An overview.Expert Rev Neurother,2012,12:1133-1142. 16 Rizzoli P,Preventive pharmacotherapy in migraine.Headache,2014,54:364-369. 17 Martelletti P,Guglielmetti M.Approaching the appropriate pharmacotherapy of menstrual migraine.Expert Rev Neurother,2020,20:1-2. 18 Meador KJ,Baker GA,Browning N,et al.Fetal antiepileptic drug exposure and cognitive outcomes at age byeares(NEAD Study):a prospective observational study.Lancet Nearol,2013,12:244-252 19 Linde M,Mulleners WM,Chronicle EP,et al.,Topiramate for the prophylaxis of episodic migraine in adults.Cochrane Database Syst Rev,2013,6:CD010610. 20 Krusz JC.Levetiracetam as prophylaxis for resistant headaches.Cephalalgia,2001,21:2-12. 21 Pizza V,Busillo A,Agresta A,et al.Elderly patients withmigraine:an open-label study on prophylaxis therapy withlevetiracetam.Cent Nerv Syst Agents Med Chem,2011,11 :31-34. 22 Sadeghian H,Motiei-Langroudi R,Comparison of levetiracetam and sodium valproate in migraine prophylaxis:a randomized placebo-controlled study.Ann Indian Acad Neurol,2015,18:45–48. 23 Li Q,Chen C,High-field MRS study of GABA+ in patients with migraine:response to levetiracetam treatment.Neuroreport,2018,29:1007-1010. 24 Ann P,Donna K,Lisa M,Levetiracetam prophylaxis in pediat-ric migraine:an open- label study.Headache,2007,47:427-430. 25 宋丽丽,左乙拉西坦预防难治性偏头痛的疗效及安全性分析.中国现代药物应用,2016,10:162-163. 26 Amery WK,Flunarizine,a calcium channel blocker:a new prophylactic drug in migraine.Headache,1983,23:70 -74. 27 Migraine prophylaxis:flunarizine.National Institute for Clinical Excellence,2014 [Available from:http://nice.org.uk/guidance/esuom33. 28 Karsan N,Marin J,Bhola R,et al.Flunarizine in primary headache disorders.Cephalalgia..An international journal of headache,2015,35:1 -296. 29 Akerman S,Holland PR,Goadsby PJ,Diencephalic and brainstem mechanisms in migraine.NatureRev Neurology,2011,12:570 -584. 30 Goadsby PJ,Holland PR,Martins -Oliveira M,et al.Pathophysiology of migraine:A disorder of sensory processing.Physiological Rev,2017,97:553 -622. 31 Karsan N,Palethorpe D,Rattanawong W,et al.Flunarizine in migraine-related headache prevention:results from 200 patients treated in the UK.Eur J Neurol 2018,25:811-817. 32 徐涛.左乙拉西坦及与氟桂利嗪联合预防偏头痛的疗效对比.世界最新医学信息文摘,2018,18:111. 33 汪新伟,欧阳寅磊.左乙拉西坦与氟桂利嗓联合预防偏头痛的临床分析.当代医学,2016,22:137-138. 34 李运良,左乙拉西坦联合氟桂利嗪预防顽固性偏头痛47例.临床医药,2015,24:80-81. 35 王发旺,余莲桂.左乙拉西坦联合盐酸氟桂利嗪治疗血管神经性头痛的疗效及对患者血清CGRP、SP水平的影响.广西医科大学学报,2017,34:1784-1786.
